NasdaqGS - Nasdaq Real Time Price • USD
Compare
As of 11:41 AM EDT. Market Open.
Line
Candle
Baseline
Mountain
Bar
Loading Chart for MMSI
9/21 12:03 PM
DELL
Date | |
Close | |
Open | |
High | |
Low | |
Volume |
- Previous Close
90.92 - Open
90.82 - Bid 90.81 x 200
- Ask 91.31 x 100
- Day's Range
90.37 - 91.07 - 52 Week Range
62.58 - 91.85 - Volume
25,629 - Avg. Volume
417,083 - Market Cap (intraday)
5.297B - Beta (5Y Monthly) 0.88
- PE Ratio (TTM)
45.27 - EPS (TTM)
2.01 - Earnings Date Oct 24, 2024 - Oct 28, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
98.55
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
6,950
Full Time Employees
December 31
Fiscal Year Ends
Healthcare
Sector
Industry
More about Merit Medical Systems, Inc.
Recent News: MMSI
View MoreAll SEC Filings
Corporate Changes & Voting Matters
Periodic Financial Reports
Proxy Statements
Tender Offer/Acquisition Reports
Offering Registrations
Performance Overview: MMSI
Trailing total returns as of 8/21/2024, which may include dividends or other distributions. Benchmark is
YTD Return
MMSI
19.80%
S&P 500
17.63%
1-Year Return
MMSI
33.88%
S&P 500
28.41%
3-Year Return
MMSI
31.46%
S&P 500
26.33%
5-Year Return
MMSI
157.64%
S&P 500
93.45%
Compare To: MMSI
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
91.00
+0.09%
Mkt Cap 5.297B
Industry Medical Instruments & Supplies
156.16
+0.59%
Mkt Cap 3.814B
Industry Medical Instruments & Supplies
74.52
+0.61%
Mkt Cap 3.814B
Industry Medical Instruments & Supplies
67.22
+0.07%
Mkt Cap 233.732M
Industry Medical Instruments & Supplies
25.75
0.00%
Mkt Cap 381.015M
Industry Medical Instruments & Supplies
237.54
+0.21%
Mkt Cap 11.192B
Industry Medical Instruments & Supplies
7.51
-0.86%
Mkt Cap 302.276M
Industry Medical Instruments & Supplies
92.68
-3.35%
Mkt Cap 18.454B
Industry Medical Instruments & Supplies
148.12
+0.01%
Mkt Cap 9.833B
Industry Medical Instruments & Supplies
49.67
-0.46%
Mkt Cap 2.43B
Industry Medical Instruments & Supplies
19.06
-1.35%
Mkt Cap 5.201B
Industry Medical Instruments & Supplies
Statistics: MMSI
View More
Valuation Measures
As of 8/20/2024
Market Cap
5.29B
Enterprise Value
5.53B
Trailing P/E
45.23
Forward P/E
27.40
PEG Ratio (5yr expected)
2.38
Price/Sales (ttm)
4.09
Price/Book (mrq)
4.13
Enterprise Value/Revenue
4.25
Enterprise Value/EBITDA
20.15
Financial Highlights
Profitability and Income Statement
Profit Margin
9.02%
Return on Assets (ttm)
4.48%
Return on Equity (ttm)
9.45%
Revenue (ttm)
1.3B
Net Income Avi to Common (ttm)
117.43M
Diluted EPS (ttm)
2.01
Balance Sheet and Cash Flow
Total Cash (mrq)
636.91M
Total Debt/Equity (mrq)
67.93%
Levered Free Cash Flow (ttm)
178.88M
Research Analysis: MMSI
View MorePeople Also Watch
ICUI ICU Medical, Inc.
156.16
+0.59%
CNMD CONMED Corporation
67.87
-0.15%
OFIX Orthofix Medical Inc.
16.53
+1.04%
NEOG Neogen Corporation
16.47
+0.95%
HAE Haemonetics Corporation
74.52
+0.61%
IART Integra LifeSciences Holdings Corporation
20.87
+0.07%
ANGO AngioDynamics, Inc.
7.51
-0.86%
LMAT LeMaitre Vascular, Inc.
86.11
+0.88%
ATRC AtriCure, Inc.
23.88
+1.10%
ITGR Integer Holdings Corporation
122.65
+0.55%
OMCL Omnicell, Inc.
42.96
+1.87%
SRDX Surmodics, Inc.
40.10
+0.20%
LIVN LivaNova PLC
46.41
+1.18%
ENSG The Ensign Group, Inc.
143.26
-0.32%
IPAR Inter Parfums, Inc.
124.98
+0.75%
MLAB Mesa Laboratories, Inc.
128.30
-0.04%